Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-07

Clinical Trial Update: Tailored Hospital-based Risk Reduction to Impede Vascular Events After Stroke [NA]

View source ↗

Summary

The document reports the completion of a study titled 'Tailored Hospital-based Risk Reduction to Impede Vascular Events After Stroke.' The sponsor is the Medica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Medical University of South Carolina | Conditions: Stroke | NA | Status: COMPLETED